LJI joins national effort to prevent pandemics by harnessing the fascinating science of x-ray crystallography
With new funding, LJI scientists will help lay the groundwork for faster vaccine and therapeutic development
With new funding, LJI scientists will help lay the groundwork for faster vaccine and therapeutic development
LJI scientists share their visions for more effective, longer-lasting vaccines
LJI Research Assistant Professor Alba Grifoni, Ph.D., shares how her T cell research could propel vaccine development
Alba Grifoni, Ph.D., studies immune response to viral infections through a combination of bioinformatics and experimental approaches. Her work is important for understanding how T cell responses recognize a range of pathogens, including Coronaviruses (SARS-CoV-2 and other subgenera), Orthopoxviruses (Mpox and Vaccinia), and other emerging pathogens.
LA JOLLA, CA — Paramyxoviruses have the potential to trigger a devastating pandemic. This family of viruses includes measles, Nipah
Erica Ollmann Saphire, Ph.D., MBA, studies, at the molecular level, how and why viruses are pathogenic. This work provides the roadmap for medical defense.
Alessandro Sette, Dr.Biol.Sci., defines in chemical terms the specific structures (epitopes) that the immune system recognizes and uses this knowledge to measure and understand immune responses.
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) is honored to announce that Dr. Erica Ollmann Saphire, one of the